Resistant Type | Number | Â | Â | Â | Â | Â | Â | Â | Â |
---|---|---|---|---|---|---|---|---|---|
MDR | 52 | Â | Â | Â | Â | Â | Â | Â | Â |
Mono_Resistant | 1 | Â | Â | Â | Â | Â | Â | Â | Â |
Poly_Resistant | 10 | Â | Â | Â | Â | Â | Â | Â | Â |
XDR | 6 | Â | Â | Â | Â | Â | Â | Â | Â |
History | Resistants | Â | Â | Â | Â | Â | Â | Â | Â |
Diagnostic | 47 | Â | Â | Â | Â | Â | Â | Â | Â |
Follow Up | 22 | Â | Â | Â | Â | Â | Â | Â | Â |
Disease Type | Resistants | Â | Â | Â | Â | Â | Â | Â | Â |
Extra Pulmonary | 3 | Â | Â | Â | Â | Â | Â | Â | Â |
Pulmonary | 66 | Â | Â | Â | Â | Â | Â | Â | Â |
Sample Type | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 | BAL | Pus | Sputum |  |  |  |  |  |  |
Resistant | 1 | 2 | 66 | Â | Â | Â | Â | Â | Â |
Gender | Resistant | Â | Â | Â | Â | Â | Â | Â | Â |
Female | 44 | Â | Â | Â | Â | Â | Â | Â | Â |
Male | 25 | Â | Â | Â | Â | Â | Â | Â | Â |
Resistant level of other drugs in PZA resistance isolates | |||||||||
 | INH | RIF | EMB | OFX | SM | KAN | CAP | AM | MOX |
Resistant | 64 | 58 | 35 | 35 | 28 | 13 | 11 | 11 | 2 |
sensitive | 5 | 11 | 34 | 34 | 40 | 56 | 58 | 58 | 67 |